Table 3.
OR | 95% CI | P | |
---|---|---|---|
Age (per 1 year) | 1·02 | 1·01, 1·03 | <0·001 |
Sex | 0·55 | ||
Female | 1·00 | Reference | |
Male | 1·10 | 0·81, 1·48 | |
Race | 0·60 | ||
Non-white | 1·00 | Reference | |
White | 0·90 | 0·60, 1·34 | |
Patient type | |||
Medical | 1·00 | Reference | 0·13 |
Surgical | 0·61 | 0·32, 1·15 | |
Deyo–Charlson Index | |||
0–3 | 1·00 | Reference | |
4–6 | 1·77 | 1·19, 2·62 | 0·005 |
≥7 | 2·12 | 1·46, 3·09 | <0·001 |
Pre-hospital 25(OH)D (ng/ml) | |||
<10 | 2·15 | 1·32, 3·50 | 0·002 |
10–19·9 | 1·54 | 0·98, 2·43 | 0·063 |
20–29·9 | 1·23 | 0·76, 1·99 | 0·39 |
≥30 | 1·00 | Reference |
25(OH)D, 25-hydroxyvitamin D.
Adjusted OR were estimated by a multivariable logistic regression model with inclusion of covariate terms considered to plausibly associate with vitamin D status and HANOD. Estimates for each variable are adjusted for all other variables in the table.